Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Short term Debt (2021)

Historic Short term Debt for Barinthus Biotherapeutics (BRNS) over the last 1 years, with Q4 2021 value amounting to $159000.0.

  • Barinthus Biotherapeutics' Short term Debt changed N/A to $159000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $159000.0, marking a year-over-year change of. This contributed to the annual value of $159000.0 for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q4 2021, Barinthus Biotherapeutics' Short term Debt is $159000.0.
  • Barinthus Biotherapeutics' Short term Debt's 5-year high stood at $159000.0 during Q4 2021, with a 5-year trough of $159000.0 in Q4 2021.